New York City Finds One in Five Adults has Mental Health Problems November 12, 2015

At least one in five adult New Yorkers suffer from depression, substance abuse, suicidal thoughts or other psychological disorders every year, according to a report released on Thursday ahead of Mayor Bill de Blaiso’s new mental-health initiative. New York City’s Department of Health and Mental Hygiene expects to release the plan, known as NYC Thrive,Read More

[Continue reading…]

Emergency Department Visits Related to Schizophrenia Among Adults Aged 18–64: United States, 2009–2011

A new NCHS report describes the rate and characteristics of emergency department (ED) visits related to schizophrenia among adults aged 18–64. Key Findings from the Report: During 2009–2011, an estimated 382,000 ED visits related to schizophrenia occurred each year among adults aged 18–64, with an overall ED visit rate of 20.1 per 10,000 adults. The overall rateRead More

[Continue reading…]

Schizophrenia Treatment: How does your state rank?

Clozapine is an antipsychotic medication used to treat the 20 to 30 percent of Schizophrenic patients who do not respond to other medications. This medication is referred to as the “gold standard” of Schizophrenia medications and, according to an expert on Schizophrenia, should be prescribed to at least 10% of people with Schizophrenia. A reportRead More

[Continue reading…]

Phone Support Groups

Family and Friends Support Group Not for Individuals Diagnosed Every Tuesday ­ 7 pm Eastern Time Frequent Guest Speakers   SA Conference Call Groups For Individuals Diagnosed Every Sunday, Thursday and Friday 7 pm Eastern Time   Spirit of SA Conference Call For SA Leaders and potential Leaders First Wednesday of Each Month 7 pmRead More

[Continue reading…]

A STORY OF RECOVERY

by Brian D. On May 15, 1980, I graduated from The University of Connecticut School of Law.  I had no worries, except my studies, as my parents paid virtually all my bills until I was 25 years old. In college at Miami University, in Oxford, Ohio, I had a work study job, and for oneRead More

[Continue reading…]

Can playing video games improve your health?

A new study posted in Psychiatric Services has linked playing video games to better health. In the study patients with Schizophrenia participated in a 12 week program where they exercised for 1 hour, three times a week. The study found that the patients, who were given multiple choices of aerobic exercise options, chose active-play videoRead More

[Continue reading…]

Largest Schizophrenia and Schizoaffective Disorder Caregiver Survey Reveals Overwhelming Burden and Inadequate Assistance

In recognition of National Family Caregivers Month, Janssen Pharmaceuticals, Inc. announced results of “A Large-Scale Survey of Caregivers of Persons with Schizophrenia and/or Schizoaffective Disorder Designed to Identify Unmet Needs” that showed caregiving is a significant burden and caregivers lack sufficient support and assistance. The study was recently presented at the Academy of Managed Care Pharmacy’s NEXUS 2015 Congress. TheRead More

[Continue reading…]

Investigational Antipsychotic Eases Negative Symptoms of Schizophrenia Caripraszine

Cariprazine, a novel antipsychotic being developed by Hungarian drug maker Gedeon Richter Plc, proved more effective than risperidone for negative symptoms of schizophrenia in a phase 3 randomized controlled trial, company researchers have reported. To read the complete article by Reuters, please click here. Print PDF

[Continue reading…]

Join the photo collage/movement with SARDAA on NoFearNow portal

nofearnow

SARDAA is supporting a photo collage/movement to inspire people to have no fear regarding their mental health issues. We are looking for people who have or have loved ones who have lived with a brain disorder/mental health issue to share their experience for a new #NoFearNow anti-stigma campaign. Participating is simple. Simply email to info@lightwoundsmovie.com:Read More

[Continue reading…]

Study Finds SGAs Do Not Substantively Increase Risk of Major Birth Defects

The use of second-generation antipsychotics (SGAs) during the first trimester does not appear to substantively increase the risk of major birth malformations, according to a report published in AJP in Advance. Given that discontinuation of medication during pregnancy can lead to relapse or worsening of illness in patients with psychiatric disorders, the results challenge the clinicalRead More

[Continue reading…]